PRA Group (PRAA) was trading lower after Citizens downgraded the stock, citing the business appears to be several years away from delivering reliably consistent profitability.

On 15 January 2026, the Prudential Regulation Authority ("PRA") published its annual letter setting out supervisory priorities for the UK ...

PRA Group allowed inefficiencies and operational issues in collections, purchasing, and overall operations to accumulate, driving terrible results in 2023 and a change in management. New management ...

Researchers have identified a genetic mutation causing progressive retinal atrophy (PRA) in the Phalene and Papillon dog breeds. PRA is one of the most common causes of blindness in dogs and in human.

Contract research organization PRA Health has launched a new mobile app aimed at tracking patients’ physical and psychological symptoms from COVID-19. The new app, the CRO explains, allows employers, ...

PRA Group’s consensus analyst price target has recently shifted, moving from $23.33 to $22.67. This adjustment reflects a mix of confidence and caution among analysts, who are weighing improved ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L) 0.06% U.S. Bancorp Dep. Pfd. (Rep. 1/1000 Interest in a share of Non-Cum Perp Pfd Series B) 0.69% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th ...

RALEIGH, N.C. – PRA, a leading clinical research organization, today announced it has acquired privately held ClinStar, LLC, a clinical research organization managing Phase I-IV clinical research ...

Plunkett Raysich Architects (PRA) Acquires Iowa-Based Align Architecture & Planning MILWAUKEE, WI, October 7, 2024 — Plunkett Raysich Architects, LLP (PRA), a leading Milwaukee-Based architecture and ...

PRA Group Inc (NASDAQ:PRAA) is set to release its Q1 2025 earnings on May 5, 2025. The consensus estimate for Q1 2025 revenue is $285.97 million, and the earnings are expected to come in at $0.44 per ...

RALEIGH, N.C.--(BUSINESS WIRE)--PRA International (“PRA”), a leading clinical research organization, today announced the completion of its merger with ReSearch Pharmaceutical Services (“RPS”) and the ...

The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...